is a global, peer-reviewed, open access lupus journal from LFA, publishing papers on all aspects of lupus and related diseases.

Xinya Tong, Wenwen Chen, Lele Ye, Yanling Xiong, Yuan Xu, Yunhui Luo, Xinhang Xia, Zexia Xu, Yutong Lin, Xinqi Zhu, Nan Wang, Xiangyang Xue, Huidi Zhang, Gangqiang Guo ...

No HTML tags allowed. Web page addresses and e-mail addresses turn into links automatically. Lines and paragraphs break automatically.

The Lupus Foundation of America is a charitable organization with tax-exempt status granted under Section 501(c)(3) of the Internal Revenue Code. The LFA’s Federal ID# is 43-1131436. Donations are tax ...

Background Neuropsychiatric symptoms are highly prevalent among systemic lupus erythematosus (SLE) patients, being clinically observed in up to 80% of adult and 95% of pediatric patients. Type 1 ...

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2- to 10-fold higher risk of ischemic heart ...

Case 1. A 75-year-old woman with erythematous-scaling plaque of the nose A 75-year-old woman presented with a unique erythematous-scaling plaque of the nose. A skin biopsy showed an interface ...

Sign up here to receive an email when new content is published in the journal. If you are already signed up, you can manage your preferences on MyAccount.

How can I track my submitted paper? You can find the status of your manuscript by entering your Manuscript ID on Where Is My Paper? It will also be visible in your Author Dashboard on the manuscript ...

TitleAuthorDate Evaluation of the effects of pre-exposure treatment with hydroxychloroquine on the risk of COVID-19 infection and on the efficacy of anti-COVID-19 vaccination during lupus or ...

Background Mycophenolate mofetil (MMF) is commonly used to treat SLE, but many patients experience gastrointestinal (GI) side effects, which are responsible for drug discontinuation in up to 30 ...

CoronaVac (SARS-CoV-2 inactivated vaccine) has been largely used as the main immunogen for COVID-19 in several countries; however, its immunogenicity, antibody decay and booster dose response in ...